Next Article in Journal
Methimazole-Induced ANCA Vasculitis: A Case Report
Previous Article in Journal
Positive Predictive Value of Panoramic Radiography for Assessment of the Relationship of Impacted Mandibular Third Molars with the Mandibular Canal Based on Cone-Beam Computed Tomography: A Cross-Sectional Study
Previous Article in Special Issue
Diagnostic Insights from Plethysmographic Alveolar Pressure Assessed during Spontaneous Breathing in COPD Patients
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Diagnostics
Volume 11
Issue 9
10.3390/diagnostics11091579
diagnostics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Impaired Ciliary Beat Frequency and Ciliogenesis Alteration during Airway Epithelial Cell Differentiation in COPD

by
Julien Ancel
1,2,
Randa Belgacemi
1,
Zania Diabasana
1,
Jeanne-Marie Perotin
1,2,
Arnaud Bonnomet
1,3,
Maxime Dewolf
2,
Claire Launois
2,
Pauline Mulette
1,2,
Gaëtan Deslée
1,2,
Myriam Polette
1,4 and
Valérian Dormoy
1,*
1
Inserm UMR-S1250, P3Cell, Université de Reims Champagne Ardenne, SFR CAP-SANTE, 51092 Reims, France
2
Department of Respiratory Diseases, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, 51092 Reims, France
3
Platform of Cellular and Tissular Imaging (PICT), Université de Reims Champagne Ardenne, 51097 Reims, France
4
Department of Biopathology, Centre Hospitalier Universitaire de Reims, Hôpital Maison Blanche, 51092 Reims, France
*
Author to whom correspondence should be addressed.
Diagnostics 2021, 11(9), 1579; https://doi.org/10.3390/diagnostics11091579
Submission received: 27 May 2021 / Revised: 25 August 2021 / Accepted: 27 August 2021 / Published: 31 August 2021
(This article belongs to the Special Issue Novel Markers to Explore COPD)
Browse Figures
Versions Notes

Abstract

:
Chronic obstructive pulmonary disease (COPD) is a frequent respiratory disease. However, its pathophysiology remains partially elucidated. Epithelial remodeling including alteration of the cilium is a major hallmark of COPD, but specific assessments of the cilium have been rarely investigated as a diagnostic tool in COPD. Here we explore the dysregulation of the ciliary function (ciliary beat frequency (CBF)) and differentiation (multiciliated cells formation in air-liquid interface cultures) of bronchial epithelial cells from COPD (n = 17) and non-COPD patients (n = 15). CBF was decreased by 30% in COPD (11.15 +/− 3.37 Hz vs. 7.89 +/− 3.39 Hz, p = 0.037). Ciliary differentiation was altered during airway epithelial cell differentiation from COPD patients. While the number of multiciliated cells decreased (p < 0.005), the number of primary ciliated cells increased (p < 0.05) and primary cilia were shorter (p < 0.05). Altogether, we demonstrate that COPD can be considered as a ciliopathy through both primary non-motile cilia modifications (related to airway epithelial cell repair and remodeling) and motile cilia function impairment (associated with decrease sputum clearance and clinical respiratory symptoms). These observations encourage considering cilia-associated features in the complex COPD physiopathology and highlight the potential of cilia-derived biomarkers for diagnosis.

1. Introduction

Chronic obstructive pulmonary disease (COPD) is a common respiratory disease characterized by persistent respiratory symptoms and airflow limitation [1], mainly caused by tobacco smoke and pollutants exposure. While its pathogenesis remains unclear, airway epithelial remodeling appears as a hallmark of COPD [2]. Respiratory symptoms including cough, dyspnea, sputum, and chronic bronchitis are frequent. Combined with airway inflammation [3], mucociliary clearance dysfunction and more especially ciliary epithelial airway impairment may play a key role [4].
Previous studies restricted to nasal brushes demonstrated a decreased ciliary beat frequency (CBF) in COPD patients [5,6,7]. In vitro studies on air-liquid interface (ALI) epithelia from non-COPD and COPD patients did not identify alteration of CBF [8]. We previously explored ciliary dysfunction in COPD regarding airway epithelium differentiation from bronchial cells. We observed that epithelial differentiation was altered in COPD patients, resulting from the dysregulation of the sonic hedgehog signaling [9,10], also supported by non-motile primary cilia (PC) abnormalities [11]. Nonetheless, we did not assess the functionality of the cilia and we only characterized the alteration of ciliogenesis during differentiation on airway epithelial cells isolated from nasal polyp samples. In addition, we recently evidenced via bioinformatics an abnormal cilia-associated genomic signature in COPD patients suggesting a COPD endotype exhibiting ciliopathy features that we named CiliOPD [12]. Here, we hypothesized that the homeostasis of motile cilia function (explored by ciliary beat frequency) and bronchial airway epithelial ciliated cell differentiation are both orchestrated by primary ciliogenesis. Their alterations in COPD patients may originate from dysregulation of primary cilia, an organelle often neglected as a diagnostic tool in respiratory diseases except in the context of primary ciliary dyskinesia [13].

2. Materials and Methods

2.1. Study Population

COPD and non-COPD control subjects were prospectively recruited from the Department of pulmonary medicine, University Hospital of Reims (France). Non-COPD controls were subjects with no diagnosis of chronic respiratory disease. COPD patients were enrolled based on clinical and functional assessments with a forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) < 0.7 after bronchodilation. At inclusion, all patients were stable with no acute exacerbation of COPD for 4 weeks. Patients with asthma, cystic fibrosis, tuberculosis, cancer, or other chronic respiratory disease were excluded. Patient characteristics, including demographic data, medical history, treatments, respiratory symptoms, and pulmonary function tests (PFT), were collected. Subjects who had ceased smoking for more than 6 months were considered to be ex-smokers. The severity of COPD was determined according to the spirometric classification (GOLD 1: FEV1 ≥ 80% predicted, GOLD 2: 50% ≤ FEV1 < 80% predicted, GOLD 3: 30% ≤ FEV1 < 50% predicted, GOLD 4: FEV1 < 30% predicted). Frequent exacerbations were defined as at least two exacerbations in the past 12 months [14,15]. All subjects provided written informed consent to the study (Research and Innovation in Chronic Inflammatory Respiratory Diseases-RINNOPARI, NCT02924818). All subjects underwent fiberoptic bronchoscopy with bronchial brushing under routine clinical conditions according to international guidelines [16].

2.2. Flexible Fiberoptic Bronchoscopy Procedure

Fiberoptic bronchoscopies were performed under local anesthesia with routine clinical conditions according to international guidelines [16]. Briefly, with monitoring of oxygen saturation, cavum, larynx, vocals cords, and trachea were successively anesthetized. After a careful evaluation of macroscopic endo-bronchial lesions, bronchial brushes were realized in the right lower lobe (4–5th order division). Three bronchial brushes per patient were collected.

2.3. Human Primary Airway Epithelial Cell Cultures

Fresh airway epithelial cells (AEC) obtained from bronchial brushings (right lower lobe) were suspended within 30 min in RPMI (1% penicillin/streptomycin+ 10% BSA) before centrifugation (12,500 rpm twice). The cell pellet was dissociated in 1 mL of Trypsin-Versene® (Sigma-Aldrich, Saint Quentin Falavier, France), centrifuged (12,500 rpm twice), and counted with ADAM (NanoEnTek, ThermoFisher Scientific, Waltham, MA, USA) according to NanoEnTek instructions. Total of 200,000 cells were seeded on 12-well plates containing 0.4 µm Polyester Membrane Transwell-Clear Permeable Supports (Cat. No. 3460, Corning, Fisher Scientific; 4 × 106 pores/cm2) coated with 0.3 mg/mL collagen type IV from the human placenta (Sigma-Aldrich, Saint Quentin Falavier, France) to establish ALI cultures (passage 0) as described by us and others [10,17,18,19,20,21,22]. PneumaCult-EX (PnC-Ex) media (StemCell, Saint-Egrève, France) was used for initial proliferation in apical and basal chambers. Upon reaching cell confluency after 3 to 5 cell divisions, the apical medium was removed and PneumaCult-ALI (PnC-ALI, StemCell) medium was used in the basal chamber. The culture medium was changed three times a week and cells were kept in incubators at 37 °C, 5% CO2. Cells and supernatants were collected every 7 days for 35 days to generate kinetic analysis. The quantity of cell divisions during the course of the cell culture is 5 to 7 and this is homogenous between biological samples.

2.4. Immunofluorescence Staining

Methanol-fixed AEC from ALI cultures were rehydrated by decreasing methanol concentration before post-fixation with acetone. Cells were then blocked with 10% BSA in PBS for 2 h at room temperature and incubated with the primary antibody Arl13b (17711-1-AP, Proteintech, Manchester, UK) to detect cilia as previously described [23,24,25,26] for one night at 4 °C in 3% BSA in PBS. Cells were washed with PBS and incubated with the appropriate secondary antibodies in PBS for 2 h at room temperature. DNA was stained with DAPI during incubation with the secondary antibodies. Clarification of cells was achieved by a glycerol gradient (25%/50%/75%) before mounting the slides. Micrographs were acquired on a Zeiss AxioImager microscope (20× Ph and 63×) with ZEN software (version 8.1, 2012, Zeiss, Marly le Roi, France) and processed with ImageJ (National Institutes of Health, version 2.2.0, Bethesda, MD, USA) for analysis. We routinely control the specificity of the cilia labelling with co-staining and we perform negative and positive controls for each set of experiment [11,27]. The density of multiciliated cells (MCC) was evaluated with the average pixel density of the fluorescence associated to cilia staining as previously described [10]. The percentage of primary ciliated cells and the average cilia length were automatically quantified with CiliaQ as previously described [28].

2.5. CBF Analysis

Within 30 min after collection, 200,000 fresh cells were seeded on non-coated µ-Dish 35 mm dishes (Ibidi, 81156) in 400 µL of RPMI (1% penicillin/streptomycin+ 10% BSA) and observed with a video microscope (Axio Observer Z1, Zeiss). At least five acquisitions were acquired by sample (40×- 500 images by 20 ms of exposition). CBF analysis was then performed using CiliaFA as described previously [29] (Supplemental Figure S1).

2.6. PCR Analysis

Total RNA from at least 1,000,000 frozen AEC was isolated by High Pure RNA isolation kit (11828665001, Roche Diagnostics, Basel, Switzerland) and quality was assessed with a NanodropTM 2000 spectrophotometer (Ozyme, Saint-Cyr-l’École, France) to warrant the lack of contaminants and a quantity of total RNA larger than 50 ng/µL. Then, 250 ng was reverse-transcribed into cDNA by Transcriptor First Stand cDNA Synthesis kit (04897030001, Roche Diagnostics) as recommended by the manufacturer with the following conditions: preparation (65 °C, 10 min with 60 µM random hexamer primer); cDNA synthesis (25 °C, 10 min; 55 °C, 30 min; 85 °C, 5 min; 4 °C on hold) in a final volume of 20 µL. Quantitative PCR reactions were performed in duplicate with fast Start Universal Probe Master kit and UPL-probe system (04914058001, Roche Diagnostics) in a LightCycler 480 Instrument (Roche Diagnostics) as recommended by the manufacturer with the following program for 12.5 pg of cDNA in a total volume of 12 µL: pre-incubation (95 °C, 10 min); 40 cycles of amplification (95 °C, 10 s; 60 °C, 30 s; 72 °C, 1 s); cooling (40 °C, 30 s). Specific primers (Eurogentec) were: CK5 forward 5′-TTCATGAAGATGTTCTTTGATGC-3′, reverse 5′-AGGTTGCGGTTGTTGTCC-3′ (amplicon length = 95 nt; probe #55); FOXJ1 forward 5′-CAGATCCCACCTGGCAGA-3′, reverse 5′-CGTACTGGGGGTCAATGC-3′ (amplicon length = 123 nt; probe #7); MUC5AC forward 5′-CACGTCCCCTTCAATATCCA-3′, reverse 5′-GGCCCAGGTCTCACCTTT-3′ (amplicon length = 91 nt; probe #33); MCIDAS forward 5′-CATCTGCCCCAACAGAATG-3′, reverse 5′-GATCCTCGTACACCGACACC (amplicon length = 140 nt; probe #55); HEATR2 forward 5′-ATCCTGTCCACCGTGCTG-3′, reverse 5′-CCAGGATGTCCTTTGTCACC-3′ (amplicon length = 94 nt; probe #33); RFX2 forward 5′-CTCAACCGCGTGGACTTT-3′, reverse 5′-CACACTCTCCTCGCACTGG-3′ (amplicon length = 69 nt; probe #68). Results for all expression data regarding transcripts were normalized to the expression of the house-keeping gene GAPDH amplified with the following primers: forward 5′-ACCAGGTGGTCTCCTCTGAC-3′, reverse 5′-TGCTGTAGCCAAATTCGTTG-3′ (amplicon length = 129 nt; probe #25). Relative gene expression was assessed by the ΔΔCt method [30] and expressed as fold change (log2, AB5E1 vs. control) when indicated.

2.7. Statistical Analysis

Quantitative variables were described with whisker plots as median; interquartile range and clinical parameters were represented with dot plot and median. Qualitative variables were compared using Fisher exact test. According to a limited number of patients, non-parametric Mann–Whitney and Kruskall–Wallis tests were used as appropriate. In all exploratory analyses, results with two-sided p-value < 0.05 were considered significant. The XLSTAT software (version 2019.1.3, Addinsoft, Paris, France) was used to analyze and reformat data within Excel for statistical analysis and represented with Prism (version 8, GraphPad software, San Diego, CA, USA).

3. Results

Thirty-two patients were included in the study: 17 COPD patients and 15 non-COPD patients (73% current or ex-smokers). Among COPD patients, the whole spectrum of spirometric severity was represented with a mean forced expiratory volume in one second (FEV1) of 54% (predicted value). The main characteristics of the patients are detailed in Table 1. Isolated AEC from the bronchial brushes were used to measure the CBF and establish ALI cultures.
Exploring CBF on isolated airway epithelial cells (AEC) from bronchial brushes, we first confirmed the alteration of CBF in COPD patients. We measured a significant 30% decrease of CBF (11.15 +/− 3.37 Hz in non-COPD patients vs. 7.89 +/− 3.39 in COPD patients, p < 0.05) (Figure 1 and Supplemental Video S1 and S2).
Then, we investigated multiciliated cell (MCC) formation during differentiation in AEC ALI cultures. We observed a significant two-fold decrease of MCC at ALI-21 in COPD patients (7869 +/− 1395 mean grey pixel density in non-COPD patients vs. 3939 +/− 2351 mean grey pixel density in COPD patients, p < 0.001) which was maintained at the end of differentiation at ALI-35 (11,085 +/− 1283 mean grey pixel density in non-COPD patients vs. 6335 +/− 2299 mean grey pixel density in COPD patients, p < 0.001) (Figure 2a,b). At a transcriptional level, the number of basal cells (CK5-expressing cells), mucous-secreting cells (MUC5AC-expressing cells), and MCCs (FOXJ1-expressing cells) were not significantly different in the early and late steps of AEC differentiation (Supplemental Figure S2).
We next assessed primary ciliogenesis. Since primary ciliogenesis precedes motile ciliogenesis during AEC differentiation, we focused here at an earlier in vitro time point. Motile ciliogenesis was also significantly decreased at ALI-14 in COPD patients (24.89 +/− 15.48% of MCC in non-COPD patients vs. 6.48 +/− 4.26% of MCC in COPD patients, p < 0.01) (Figure 3a,b). Interestingly, we observed an increase of PC (36.33 +/− 10.96% of cells with a PC in non-COPD patients vs. 60.22 +/− 15.58% in COPD patients, p < 0.05) (Figure 3c) which was associated with an increase of PC length (0.87 +/− 0.63 µm in non-COPD patients vs. 1.72 +/− 0.91µm in COPD patients, p < 0.05) (Figure 3d). At a transcriptional level, specific PCC markers responsible for the induction of multiciliogenesis including MCIDAS, HEATR2, and RFX2 were downregulated in COPD patients (Supplemental Figure S3). There was a significant 40% decrease of MCIDAS transcripts at ALI-7 (p < 0.05), a 60% decrease of HEATR2 transcripts at ALI-35 (p < 0.05), and a 65% decrease of RFX2 at ALI-35 (p < 0.05).

4. Discussion

Although CBF was analyzed in the context of COPD in animal models [31] or nasal brushing [5,6,7], it was only evaluated on ALI cultures of cells obtained from bronchial sampling [8], and no differences were observed between COPD-derived and non-COPD-derived cells. This prompted us to analyze CBF on bronchial AEC directly after bronchoscopy. In this condition, CBF was found to decrease suggesting that MCC may regain physiological cilia movements after repair. Nonetheless, we demonstrated that the cilia alteration persisted in COPD-derived respiratory epithelia: fewer MCC were produced while PC were more predominant and longer. This observation was consistent with our original assessment of PC alteration in COPD patients on lung tissues [11] and sustained a biological model placing the cilium at the core of cell cycle regulation and cell fate determinism [32]. Primary ciliogenesis is a necessary step during the cell cycle to orchestrate the fate of the two daughter cells: non-differentiated cells (able to form a PC) and differentiated cells (either MCC or secretory cells). Primary cilia are transient in homeostasis but their dysregulation (loss or maintenance) may induce an alteration of cell fate as we recently evidenced during AEC differentiation [27]. In COPD, the increase of PCC suggested that non-differentiated cells did not progress through the cell cycle and were blocked in G0. As a consequence, fewer non-differentiated cells initiated differentiation ultimately leading to a decrease in MCC, suggesting a global alteration of the differentiation programming. Experimental studies aiming to decipher the molecular mechanisms involved in the alteration of cilia in COPD patients are paramount to fully elucidate epithelial remodeling. This line of investigation may pave the way toward the clinical use of cilia and their abnormalities as diagnostic markers in a different spectrum of respiratory diseases such as COPD. It may also lead to considering new therapeutic pathways targeting cilium in COPD.
The cilium is a complex organelle exerting its function with molecular machinery that may only be resolved with electron microscopy. Recently, super-resolution microscopy coupled with focused ion beam scanning electron microscopy (FIB-SEM) demonstrated the presence of a hybrid cilium in MCC [33]. Exploring the structural abnormalities of all types of cilia in the context of respiratory diseases may contribute to the identification of new biomarkers. Additionally, the molecular and cellular analysis of cilia concomitant to smoke/pollutants exposure with additional technical approaches will help characterize and standardize diagnostics based on cilia dysregulation as it is routinely performed in the context of primary ciliary dyskinesia [23,34,35,36].
Since evaluating the structure and function of cilia (primary and motile) is crucial to understanding COPD pathogenesis given their involvement in mucociliary clearance, standardized investigations are required to establish guidelines in the evaluation of cilia and their alterations as diagnostic markers.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/diagnostics11091579/s1, Figure S1: Technical workflow for CBF analysis on AEC, Figure S2: Transcript levels of the main differentiation markers in non-COPD and COPD AEC-derived ALI cultures, Figure S3: Transcript levels of the main motile ciliogenesis markers in non-COPD and COPD AEC-derived ALI cultures, Video S1: Example of a videomicroscope acquisition of a multiciliated cell from a non-COPD patient, Video S2: Example of a videomicroscope acquisition of a multiciliated cell from a COPD patient.

Author Contributions

Conceptualization, J.A. and V.D.; methodology, J.A. and V.D.; formal analysis, J.A., R.B., J.-M.P., A.B., G.D. and V.D.; investigation, J.A., R.B., Z.D. and J.-M.P.; resources, J.A., J.-M.P., M.D., C.L., P.M. and G.D.; writing—original draft preparation, J.A. and V.D.; writing—review and editing, J.A., J.-M.P., G.D., M.P. and V.D.; supervision, G.D. and V.D.; project administration, V.D.; funding acquisition, G.D., M.P. and V.D. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by funding from the University of Reims Champagne-Ardenne (URCA), the French National Institute of Health and Medical Research (Inserm).

Institutional Review Board Statement

Non-COPD and COPD patients were recruited from the Department of pulmonary medicine at University Hospital of Reims (France) and included in the Research and Innovation in Chronic Inflammatory Respiratory Diseases (RINNOPARI, NCT02924818) cohort. The study was approved by the ethics committee (CCP Dijon EST I, N°2016-A00242-49) and was conducted in accordance with the ethical guidelines of the Declaration of Helsinki.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

We thank the members of the Inserm UMR-S 1250 unit and our colleagues for their helpful comments and insights. We thank the PICT platform (University of Reims Champagne-Ardenne) for technical assistance.

Conflicts of Interest

G.D. reports personal fees from Nuvaira, personal fees from BTG/PneumRx, personal fees from Chiesi, personal fees from Boehringer, personal fees from AstraZeneca, outside the submitted work. V.D. reports personal fees from Chiesi outside the submitted work. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Abbreviations

AECAirway epithelial cell
ALIAir-liquid interface
CBFCiliary beat frequency
COPDChronic Obstructive Pulmonary Disease
FEV1Forced Expiratory Volume in One second
MCCMulticiliated cell
PCPrimary cilia
PCCPrimaryciliated cell

References

  1. Riley, C.M.; Sciurba, F.C. Diagnosis and Outpatient Management of Chronic Obstructive Pulmonary Disease. JAMA 2019, 321, 786–797. [Google Scholar] [CrossRef]
  2. Capron, T.; Bourdin, A.; Perez, T.; Chanez, P. COPD beyond proximal bronchial obstruction: Phenotyping and related tools at the bedside. Eur. Respir. Rev. 2019, 28, 190010. [Google Scholar] [CrossRef]
  3. Brightling, C.; Greening, N. Airway inflammation in COPD: Progress to precision medicine. Eur. Respir. J. 2019, 54, 1900651. [Google Scholar] [CrossRef]
  4. Whitsett, J.A. Airway Epithelial Differentiation and Mucociliary Clearance. Ann. Am. Thorac. Soc. 2018, 15, S143–S148. [Google Scholar] [CrossRef]
  5. Koblizek, V.; Tomsova, M.; Cermakova, E.; Papousek, P.; Pracharova, S.; Mandalia, R.; Ceral, J.; Novosad, J.; Fila, L.; Sedlak, V.; et al. Impairment of nasal mucociliary clearance in former smokers with stable chronic obstructive pulmonary disease relates to the presence of a chronic bronchitis phenotype. Rhinol. J. 2011, 49, 397–406. [Google Scholar] [CrossRef]
  6. Yaghi, A.; Zaman, A.; Cox, G.; Dolovich, M.B. Ciliary beating is depressed in nasal cilia from chronic obstructive pulmonary disease subjects. Respir. Med. 2012, 106, 1139–1147. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Piatti, G.; Ambrosetti, U.; Santus, P.; Allegra, L. Effects of salmeterol on cilia and mucus in COPD and pneumonia patients. Pharmacol. Res. 2005, 51, 165–168. [Google Scholar] [CrossRef] [PubMed]
  8. Petit, A.; Knabe, L.; Khelloufi, K.; Jory, M.; Gras, D.; Cabon, Y.; Begg, M.; Richard, S.; Massiera, G.; Chanez, P.; et al. Bronchial Epithelial Calcium Metabolism Impairment in Smokers and Chronic Obstructive Pulmonary Disease. Decreased ORAI3 Signaling. Am. J. Respir. Cell Mol. Biol. 2019, 61, 501–511. [Google Scholar] [CrossRef] [PubMed]
  9. Ancel, J.; Belgacemi, R.; Perotin, J.-M.; Diabasana, Z.; Dury, S.; Dewolf, M.; Bonnomet, A.; Lalun, N.; Birembaut, P.; Polette, M.; et al. Sonic hedgehog signalling as a potential endobronchial biomarker in COPD. Respir. Res. 2020, 21, 1–11. [Google Scholar] [CrossRef]
  10. Belgacemi, R.; Luczka, E.; Ancel, J.; Diabasana, Z.; Perotin, J.-M.; Germain, A.; Lalun, N.; Birembaut, P.; Dubernard, X.; Mérol, J.-C.; et al. Airway epithelial cell differentiation relies on deficient Hedgehog signalling in COPD. EBioMedicine 2020, 51, 102572. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Perotin, J.-M.; Coraux, C.; Lagonotte, E.; Birembaut, P.; Delépine, G.; Polette, M.; Deslee, G.; Dormoy, V. Alteration of primary cilia in COPD. Eur. Respir. J. 2018, 52, 1800122. [Google Scholar] [CrossRef] [PubMed]
  12. Perotin, J.-M.; Polette, M.; Deslée, G.; Dormoy, V. CiliOPD: A ciliopathy-associated COPD endotype. Respir. Res. 2021, 22, 1–7. [Google Scholar] [CrossRef] [PubMed]
  13. Lucas, J.S.; Davis, S.D.; Omran, H.; Shoemark, A. Primary ciliary dyskinesia in the genomics age. Lancet Respir. Med. 2020, 8, 202–216. [Google Scholar] [CrossRef]
  14. Vogelmeier, C.F.; Criner, G.J.; Martinez, F.J.; Anzueto, A.; Barnes, P.J.; Bourbeau, J.; Celli, B.R.; Chen, R.; Decramer, M.; Fabbri, L.M.; et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am. J. Respir. Crit. Care Med. 2017, 195, 557–582. [Google Scholar] [CrossRef] [PubMed]
  15. Hurst, J.R.; Vestbo, J.; Anzueto, A.; Locantore, N.; Müllerová, H.; Tal-Singer, R.; Miller, B.; Lomas, D.A.; Agusti, A.; MacNee, W.; et al. Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease. N. Engl. J. Med. 2010, 363, 1128–1138. [Google Scholar] [CrossRef] [Green Version]
  16. Du Rand, I.A.; Blaikley, J.; Booton, R.; Chaudhuri, N.; Gupta, V.; Khalid, S.; Mandal, S.; Martin, J.; Mills, J.; Navani, N.; et al. British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: Accredited by NICE. Thorax 2013, 68, i1–i44. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Adam, D.; Roux-Delrieu, J.; Luczka, E.; Bonnomet, A.; Lesage, J.; Mérol, J.-C.; Polette, M.; Abély, M.; Coraux, C. Cystic fibrosis airway epithelium remodelling: Involvement of inflammation. J. Pathol. 2014, 235, 408–419. [Google Scholar] [CrossRef] [PubMed]
  18. Jiang, D.; Schaefer, N.; Chu, H.W. Air–Liquid Interface Culture of Human and Mouse Airway Epithelial Cells. Methods Mol. Biol. 2018, 1809, 91–109. [Google Scholar] [CrossRef] [PubMed]
  19. Schamberger, A.C.; Staab-Weijnitz, C.; Mise-Racek, N.; Eickelberg, O. Cigarette smoke alters primary human bronchial epithelial cell differentiation at the air-liquid interface. Sci. Rep. 2015, 5, 8163. [Google Scholar] [CrossRef] [Green Version]
  20. Müller, L.; Brighton, L.E.; Carson, J.L.; Ii, W.A.F.; Jaspers, I. Culturing of Human Nasal Epithelial Cells at the Air Liquid Interface. J. Vis. Exp. 2013, e50646. [Google Scholar] [CrossRef]
  21. Pezzulo, A.A.; Starner, T.D.; Scheetz, T.E.; Traver, G.L.; Tilley, A.E.; Harvey, B.-G.; Crystal, R.G.; McCray, P.B., Jr.; Zabner, J. The air-liquid interface and use of primary cell cultures are important to recapitulate the transcriptional profile of in vivo airway epithelia. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 300, L25–L31. [Google Scholar] [CrossRef] [Green Version]
  22. García, S.R.; Deprez, M.; Lebrigand, K.; Cavard, A.; Paquet, A.; Arguel, M.-J.; Magnone, V.; Truchi, M.; Caballero, I.; Leroy, S.; et al. Novel dynamics of human mucociliary differentiation revealed by single-cell RNA sequencing of nasal epithelial cultures. Development 2019, 146, dev.177428. [Google Scholar] [CrossRef] [Green Version]
  23. Lauring, M.C.; Zhu, T.; Luo, W.; Wu, W.; Yu, F.; Toomre, D. New software for automated cilia detection in cells (ACDC). Cilia 2019, 8, 1–21. [Google Scholar] [CrossRef] [Green Version]
  24. Zhang, P.; Kiseleva, A.A.; Korobeynikov, V.; Liu, H.; Einarson, M.B.; Golemis, E.A. Microscopy-Based Automated Live Cell Screening for Small Molecules That Affect Ciliation. Front. Genet. 2019, 10, 75. [Google Scholar] [CrossRef] [Green Version]
  25. Hua, K.; Ferland, R.J. Fixation methods can differentially affect ciliary protein immunolabeling. Cilia 2017, 6, 5. [Google Scholar] [CrossRef] [Green Version]
  26. Paridaen, J.T.; Huttner, W.B.; Wilsch-Bräuninger, M. Analysis of primary cilia in the developing mouse brain. In Micropatterning in Cell Biology Part B; Elsevier: Amsterdam, The Netherlands, 2015; Volume 127, pp. 93–129. [Google Scholar]
  27. Belgacemi, R.; Diabasana, Z.; Hoarau, A.; Dubernard, X.; Mérol, J.; Ruaux, C.; Polette, M.; Perotin, J.; Deslée, G.; Dormoy, V. Primary ciliogenesis is a crucial step for multiciliated cell determinism in the respiratory epithelium. J. Cell. Mol. Med. 2021, 25, 7575–7579. [Google Scholar] [CrossRef]
  28. Hansen, J.N.; Rassmann, S.; Stüven, B.; Jurisch-Yaksi, N.; Wachten, D. CiliaQ: A simple, open-source software for automated quantification of ciliary morphology and fluorescence in 2D, 3D, and 4D images. Eur. Phys. J. E 2021, 44, 1–26. [Google Scholar] [CrossRef]
  29. Smith, C.M.; Djakow, J.; Free, R.C.; Djakow, P.; Lonnen, R.; Williams, G.; Pohunek, P.; Hirst, R.A.; Easton, A.J.; Andrew, P.W.; et al. ciliaFA: A research tool for automated, high-throughput measurement of ciliary beat frequency using freely available software. Cilia 2012, 1, 14. [Google Scholar] [CrossRef] [Green Version]
  30. Zuo, W.-L.; Yang, J.; Strulovici-Barel, Y.; Salit, J.; Rostami, M.; Mezey, J.G.; O’Beirne, S.; Kaner, R.J.; Crystal, R.G. Exaggerated BMP4 signalling alters human airway basal progenitor cell differentiation to cigarette smoking-related phenotypes. Eur. Respir. J. 2019, 53, 1702553. [Google Scholar] [CrossRef]
  31. Åstrand, A.B.M.; Hemmerling, M.; Root, J.; Wingren, C.; Pesic, J.; Johansson, E.; Garland, A.L.; Ghosh, A.; Tarran, R. Linking increased airway hydration, ciliary beating, and mucociliary clearance through ENaC inhibition. Am. J. Physiol. Cell. Mol. Physiol. 2015, 308, L22–L32. [Google Scholar] [CrossRef] [Green Version]
  32. Hua, K.; Ferland, R.J. Primary cilia proteins: Ciliary and extraciliary sites and functions. Cell. Mol. Life Sci. 2018, 75, 1521–1540. [Google Scholar] [CrossRef] [PubMed]
  33. Liu, Z.; Nguyen, Q.P.; Nanjundappa, R.; Delgehyr, N.; Megherbi, A.; Doherty, R.; Thompson, J.; Jackson, C.; Albulescu, A.; Heng, Y.M.; et al. Super-Resolution Microscopy and FIB-SEM Imaging Reveal Parental Centriole-Derived, Hybrid Cilium in Mammalian Multiciliated Cells. Dev. Cell 2020, 55, 224–236. [Google Scholar] [CrossRef]
  34. Gsell, S.; Loiseau, E.; D’Ortona, U.; Viallat, A.; Favier, J. Hydrodynamic model of directional ciliary-beat organization in human airways. Sci. Rep. 2020, 10, 1–12. [Google Scholar] [CrossRef]
  35. Kempeneers, C.; Seaton, C.; Espinosa, B.G.; Chilvers, M. Ciliary functional analysis: Beating a path towards standardization. Pediatr. Pulmonol. 2019, 54, 1627–1638. [Google Scholar] [CrossRef] [PubMed]
  36. O’Callaghan, C.; Rutman, A.; Williams, G.; Kulkarni, N.; Hayes, J.; Hirst, R.A. Ciliated conical epithelial cell protrusions point towards a diagnosis of primary ciliary dyskinesia. Respir. Res. 2018, 19, 125. [Google Scholar] [CrossRef] [Green Version]
Diagnostics 11 01579 g001 550
Figure 1. Cilia beat frequency of multiciliated cells is decreased in COPD patients. Dot plot (mean +/− SD) showing the CBF in non-COPD (black, n = 10) and COPD (red, n = 10) AEC. *, p < 0.05 non-COPD vs. COPD.
Figure 1. Cilia beat frequency of multiciliated cells is decreased in COPD patients. Dot plot (mean +/− SD) showing the CBF in non-COPD (black, n = 10) and COPD (red, n = 10) AEC. *, p < 0.05 non-COPD vs. COPD.
Diagnostics 11 01579 g001
Diagnostics 11 01579 g002 550
Figure 2. Multiciliated cell generation is decreased in COPD patients. (a) Examples of micrographs taken from AEC cultures from non-COPD and COPD patients at ALI-21 and ALI-35 showing motile cilia (Arl13b, red). Nuclei are stained in blue (DAPI). (b) Dot plot (mean +/− SD) represents the mean grey values of cilia-associated fluorescence at ALI-21 and ALI-35 in non-COPD AEC-derived ALI cultures (black, n = 10) and COPD AEC-derived ALI cultures (red, n = 10). ** p < 0.01, *** p < 0.001 non-COPD vs. COPD.
Figure 2. Multiciliated cell generation is decreased in COPD patients. (a) Examples of micrographs taken from AEC cultures from non-COPD and COPD patients at ALI-21 and ALI-35 showing motile cilia (Arl13b, red). Nuclei are stained in blue (DAPI). (b) Dot plot (mean +/− SD) represents the mean grey values of cilia-associated fluorescence at ALI-21 and ALI-35 in non-COPD AEC-derived ALI cultures (black, n = 10) and COPD AEC-derived ALI cultures (red, n = 10). ** p < 0.01, *** p < 0.001 non-COPD vs. COPD.
Diagnostics 11 01579 g002
Diagnostics 11 01579 g003 550
Figure 3. Primary ciliogenesis is altered in COPD-derived AEC ALI cultures. (a) Examples of micrographs taken from AEC cultures from non-COPD and COPD patients at ALI-14 showing motile cilia and primary cilia (Arl13b, red). Nuclei are stained in blue (DAPI). Magnification corresponding to the selected area is shown. White arrowheads indicate primary cilia. Dot plot (mean +/− SD) represents the percentage of MCC (b), the percentage of primary ciliated cells (c), and the length of PC (d) at ALI-14 in non-COPD AEC-derived ALI cultures (black, n = 6) and COPD AEC-derived ALI cultures (red, n = 8). * p < 0.05, ** p < 0.01 non-COPD vs. COPD.
Figure 3. Primary ciliogenesis is altered in COPD-derived AEC ALI cultures. (a) Examples of micrographs taken from AEC cultures from non-COPD and COPD patients at ALI-14 showing motile cilia and primary cilia (Arl13b, red). Nuclei are stained in blue (DAPI). Magnification corresponding to the selected area is shown. White arrowheads indicate primary cilia. Dot plot (mean +/− SD) represents the percentage of MCC (b), the percentage of primary ciliated cells (c), and the length of PC (d) at ALI-14 in non-COPD AEC-derived ALI cultures (black, n = 6) and COPD AEC-derived ALI cultures (red, n = 8). * p < 0.05, ** p < 0.01 non-COPD vs. COPD.
Diagnostics 11 01579 g003
Table
Table 1. Baseline characteristics of the population.
Table 1. Baseline characteristics of the population.
Non-COPD
(n = 15)		COPD
(n = 17)		p-Value
Sex ratio H/F6/910/7ns
Age (years)52 ± 1560 ± 12ns
Smoking history--<0.01
Never smokers4 (26%)0<0.05
Current-smokers7 (47%)5 (29%)ns
Former-smokers4 (26%)12 (71%)<0.05
Pack-years21 ± 2541 ± 24<0.05
Spirometry---
FEV1, % of predicted value100 ± 1754 ± 29<0.0001
FVC, % of predicted value102 ± 1880 ± 22<0.05
FEV1/FVC %82 ± 1048 ± 14<0.0001
Spirometric GOLD 1/2/3/4NA4/3/6/4-
GOLD A/B/C/DNA4/4/4/5-
GOLD CATNA3/4/3/7-
Inhaled treatments---
LABANA12 (71%)-
LAMANA7 (41%)-
ICSNA8 (47%)-
Frequent exacerbation (>1/year)-7 (41%)-
Respiratory symptoms---
Dyspnea (mMRC) 0/1/2/3/44/7/2/2/04/4/5/3/1ns
Cough13 (86%)16 (94%)ns
Sputum6 (40%)13 (76%)ns
Chronic bronchitis4 (27%)8 (47%)ns
Data are expressed as mean ± SD or number (%); FEV1: forced expiratory volume in one second; FVC: forced vital capacity LABA: long-acting β2-agonist; LAMA: long-acting muscarinic-antagonist; ICS: inhaled corticosteroid; ns: non-significate.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Ancel, J.; Belgacemi, R.; Diabasana, Z.; Perotin, J.-M.; Bonnomet, A.; Dewolf, M.; Launois, C.; Mulette, P.; Deslée, G.; Polette, M.; et al. Impaired Ciliary Beat Frequency and Ciliogenesis Alteration during Airway Epithelial Cell Differentiation in COPD. Diagnostics 2021, 11, 1579. https://doi.org/10.3390/diagnostics11091579

AMA Style

Ancel J, Belgacemi R, Diabasana Z, Perotin J-M, Bonnomet A, Dewolf M, Launois C, Mulette P, Deslée G, Polette M, et al. Impaired Ciliary Beat Frequency and Ciliogenesis Alteration during Airway Epithelial Cell Differentiation in COPD. Diagnostics. 2021; 11(9):1579. https://doi.org/10.3390/diagnostics11091579

Chicago/Turabian Style

Ancel, Julien, Randa Belgacemi, Zania Diabasana, Jeanne-Marie Perotin, Arnaud Bonnomet, Maxime Dewolf, Claire Launois, Pauline Mulette, Gaëtan Deslée, Myriam Polette, and et al. 2021. "Impaired Ciliary Beat Frequency and Ciliogenesis Alteration during Airway Epithelial Cell Differentiation in COPD" Diagnostics 11, no. 9: 1579. https://doi.org/10.3390/diagnostics11091579

APA Style

Ancel, J., Belgacemi, R., Diabasana, Z., Perotin, J. -M., Bonnomet, A., Dewolf, M., Launois, C., Mulette, P., Deslée, G., Polette, M., & Dormoy, V. (2021). Impaired Ciliary Beat Frequency and Ciliogenesis Alteration during Airway Epithelial Cell Differentiation in COPD. Diagnostics, 11(9), 1579. https://doi.org/10.3390/diagnostics11091579

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop